Roy Xie - Managing Director and Head of Healthcare Investments @ Loyal Valley Capital

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

Roy Xie is the Managing Director and head of healthcare Investments of Loyal Valley Capital. Roy attended Southeast University.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Medilink Therapeutics	Loyal Valley Capital	—	Series B - Medilink Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Alebund Pharmaceuticals	Loyal Valley Capital	Yes	Series B - Alebund Pharmaceuticals	obfuscated obfuscation
obfuscated obfuscation	Arctic Vision	Loyal Valley Capital	Yes	Series B - Arctic Vision	obfuscated obfuscation
obfuscated obfuscation	Medilink Therapeutics	Loyal Valley Capital	Yes	Series A - Medilink Therapeutics	obfuscated obfuscation
obfuscated obfuscation	CARsgen Therapeutics	Loyal Valley Capital	Yes	Series C - CARsgen Therapeutics	obfuscated obfuscation

Number of Current Jobs

is the

Managing Director and Head of Healthcare Investments

Loyal Valley Capital Managing Director and Head of Healthcare InvestmentsOct 2015

Number of Current Board & Advisor Roles

is the

Board Member

Hub Name	CB Rank (Hub)
Investors Active in Shanghai, Shanghai	4,247
Asia-Pacific (APAC) Late Stage Venture Investors	1,203
Venture Stage Investors with Investments in Shanghai	3,972
Late Stage Venture Investors with Investments in Shanghai, Shanghai	1,309
Late Stage Venture Investors with Investments in China	1,892
City of Shanghai Private Equity Stage Investors	28,093
City of Shanghai Private Equity Firms	26,317
Private Equity Firms with Investments in Asia-Pacific (APAC)	6,792
Post IPO Investors with Investments in Shanghai	19,581
City of Shanghai Venture Stage Investors	12,186

There is no recent news or activity for this profile.